ZTZ-83500-15487
4 vaccinations
5 coded responses
51 check-ins
4 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 295 / SC
- Registered
- 2021-01-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-26
Registered in v-safe
-
2021-01-26
Dose 1 — Pfizer-BioNTech
- 2021-01-26
-
2021-01-27
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-01-28
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Muscle or body aches, VomitingAdult check-in
-
2021-01-29
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-30
Health check-in — days 1–6 daily, dose 1Feeling: Good · Joint pains, Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-09
- 2021-02-16
-
2021-02-17
Dose 2 — Pfizer-BioNTech
- 2021-02-18
- 2021-02-19
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-02-24
- 2021-03-03
- 2021-03-11
- 2021-03-17
- 2021-03-26
- 2021-03-31
- 2021-05-19
- 2021-08-18
-
2021-09-20
Dose 3 — Pfizer-BioNTech
- 2021-09-20
-
2021-09-21
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-09-24
Health check-in — days 1–6 daily, dose 3Feeling: Good · Headache, Muscle or body achesAdult check-in
-
2021-09-25
Health check-in — days 1–6 daily, dose 3Feeling: Good · Headache, Fatigue or tirednessAdult check-in
-
2021-09-26
Health check-in — days 1–6 daily, dose 3Feeling: Good · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-09-27
- 2021-10-04
- 2021-10-11
- 2021-10-18
- 2021-10-25
- 2021-11-01
-
2021-12-21
Survey response — 3 months, dose 3MedDRA: Myalgia, Pyrexia — Feeling: Good · Be unable to do your normal daily activitiesFree text: Mild fever and muscle achesMedDRA releases: 2024-11 · check-in free text available
- 2022-03-22
-
2022-05-05
Dose 4 — Pfizer-BioNTech
- 2022-05-05
- 2022-05-06
-
2022-05-07
Health check-in — days 1–6 daily, dose 4Feeling: Good · Headache, Joint pains, Muscle or body achesAdult check-in
-
2022-05-08
Health check-in — days 1–6 daily, dose 4Feeling: Good · Headache, Fatigue or tirednessAdult check-in
-
2022-05-09
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-05-11
Health check-in — days 1–6 daily, dose 4Feeling: Good · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-05-12
Health check-in — day 7, dose 4Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-05-19
- 2022-05-26
- 2022-06-02
-
2022-06-09
Survey response — day 35, dose 4MedDRA: Skin lesion, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Migratory round skin lesions of various sizes that somewhat resemble eczema or psoriasis which are conditions I never had prior · Healthcare visit (other): Dermatology appt. scheduledMedDRA releases: 2024-11 · check-in free text available
-
2022-06-09
Report sent to call center — day 35, dose 4Get care from a doctor or other healthcare professional1 call case(s)
- 2022-06-10
-
2022-06-17
Survey response — day 42, dose 4MedDRA: Dermatitis psoriasiform, Eczema nummular, Headache, Skin disorder — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Migratory nummular rashes that resemble eczema or psoriasis. Have never had skin issues prior. Also having more frequent headaches.MedDRA releases: 2024-11 · check-in free text available
-
2022-06-17
Report sent to call center — day 42, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-08-04
Survey response — 3 months, dose 4MedDRA: Headache, Productive cough, Self-medication — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Productive morning cough, increased headache frequency often not responsive to medicationMedDRA releases: 2024-11 · check-in free text available
-
2022-08-04
Report sent to call center — 3 months, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-08-11
- 2022-08-17
-
2022-08-17
Callback requested for01:00PM ET
- 2022-08-17
-
2022-08-17
Callback requested for01:00PM ET
- 2022-08-17
- 2022-11-03
-
2023-05-05
Survey response — 12 months, dose 4MedDRA: Arthritis, Nodal osteoarthritis, Rash, Skin depigmentation — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-05-05
Report sent to call center — 12 months, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-05-08
- 2023-05-08
- 2023-05-08
- 2023-05-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-26 | Pfizer-BioNTech | |
| 2 | 2021-02-17 | Pfizer-BioNTech | |
| 3 | 2021-09-20 | Pfizer-BioNTech | No |
| 4 | 2022-05-05 | Pfizer-BioNTech | No |
Call center
4 call center cases
4 unsuccessful
Free text
Release 10 — 3 months, dose 3
Symptoms: Mild fever and muscle aches
Release 12 — day 35, dose 4
Symptoms: Migratory round skin lesions of various sizes that somewhat resemble eczema or psoriasis which are conditions I never had prior
Healthcare visit (other): Dermatology appt. scheduled
Release 12 — day 42, dose 4
Symptoms: Migratory nummular rashes that resemble eczema or psoriasis. Have never had skin issues prior. Also having more frequent headaches.
Release 12 — 3 months, dose 4
Symptoms: Productive morning cough, increased headache frequency often not responsive to medication
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Arthritis | · | · | ✓ |
| SD | Dermatitis psoriasiform | · | · | ✓ |
| SD | Eczema nummular | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Nodal osteoarthritis | · | · | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Self-medication | · | · | ✓ |
| SD | Skin depigmentation | · | · | ✓ |
| SD | Skin disorder | · | · | ✓ |
| SD | Skin lesion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release